mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
4e-05 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
9e-05 |
mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |